Evidence map›Paper›PMID 37702428›Full record

ArticleJournal of clinical psychology2023

Clinician perspectives on technology-enhanced in vivo exposures during prolonged exposure therapy for PTSD.

Delisa G Brown, Amber M Jarnecke, Tanya C Saraiya, Elizabeth Santa-Ana, Ron Acierno, Mclain Reese, Robert Adams, William Harley, Sudie E Back

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical psychology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Delisa G BrownDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0002-3201-0428
Amber M JarneckeDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Tanya C SaraiyaDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Elizabeth Santa-AnaDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Ron AciernoRalph H. Johnson VA Medical Center, Charleston, South Carolina, USA.
Mclain ReeseZeriscope, Inc., Charleston, South Carolina, USA.
Robert AdamsDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
William HarleyZeriscope, Inc., Charleston, South Carolina, USA.
Sudie E BackDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Medical University of South Carolina · USUniversity of Charleston · USRalph H. Johnson VA Medical Center · USRutgers, The State University of New Jersey · US

Funding

The Impact of Stress and Craving on Return to Postpartum Cannabis UseU54DA016511 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CONSTANCE GUILLE · 2018 to 2026
$15.9M
Vocational Training for Drug Dependent WomenP50DA016511 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2002 to 2017
$14.5M
DRUG ABUSE TRAINING PROGRAMT32DA007288 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Christopher W Cowan, Rachel Penrod-Martin · 1991 to 2026
$11.8M
Identifying the neurobehavioral signature of individuals with AUD and comorbid PTSDK23AA027307 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JARNECKE, AMBER · 2019 to 2023
$1.0M
Intelligent Biometrics to Optimize Prolonged Exposure Treatment for PTSD (IB-PE)R43MH122045 · NIMH · ZERISCOPE, INC. · PI BACK, SUDIE E, HARLEY, WILLIAM · 2019 to 2020
$952k
NIAAA NIH HHS K23 AA027307NIAAA NIH HHS K23AA027307NIDA NIH HHS P50 DA016511NIDA NIH HHS T32 DA007288NIDA NIH HHS T32DA007288NIDA NIH HHS U54 DA016511NIMH NIH HHS R43 MH122045
6 · The paper itself

Abstract

objectiveTo investigate clinicians' perceptions regarding the use of mobile technology tools during prolonged exposure (PE) therapy to allow for monitoring and enhancing in-vivo exposures (IVEs).

methodsClinicians with training in PE therapy (N = 32; average of 9 years of practice) completed surveys asking about their perspectives on the utility of virtually attending IVEs with patients while simultaneously having access to real-time subjective and physiological data (i.e., heart rate, galvanic skin conductance) to guide exposure exercises and assure optimal stimulus engagement.

resultsFindings showed clinicians to have a favorable view of applying technology devices and systems to enhance IVEs of PE therapy. Most clinicians (93.8%) believed that real-time monitoring of IVEs-particularly monitoring patients' subjective distress and completion of and duration of time in the IVE-would be useful and significantly enhance PE therapy.

conclusionThe positive perceptions toward integrating technology into IVEs in this study have important implications for the development and implementation of technology-enhanced PE therapy. A mobile technology system that incorporates real-time indicators of engagement (i.e., both subjective and physiological) during IVEs and allows clinicians to review recordings of, or virtually accompany, patients during IVEs has the potential to innovate and transform PE and other exposure-based treatments. Clinicians also believed that technology-enhanced IVEs may help reduce early termination from PE.

Indexed as

Implosive TherapyStress Disorders, Post-TraumaticHumansSurveys and QuestionnairesTreatment Outcomeposttraumatic stress disorderprolonged exposurePTSDtechnology

Identifiers

PMID37702428
PMCPMC10840959
OpenAlexW4386704702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.